Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study

INTRODUCTION: Intravenous immunoglobulin (IVIG) is recommended as first-line therapy for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), an immune-mediated neuropathy. The clinical profile of patients with CIDP newly initiating IVIG is poorly characterized. This claims-based cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Layton, J. Bradley, Ritchey, Mary E., Huang, Zhongwen, Chavan, Shailesh, Ay, Hakan, Souayah, Nizar, Anderson-Smits, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310640/
https://www.ncbi.nlm.nih.gov/pubmed/37195408
http://dx.doi.org/10.1007/s40120-023-00479-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310640/
https://www.ncbi.nlm.nih.gov/pubmed/37195408
http://dx.doi.org/10.1007/s40120-023-00479-4

Ejemplares similares